As an inhibitor of norepinephrine release, dexmedetomidine provides no improvement on stroke-associated pneumonia in mice

Background: Dexmedetomidine (DEX) is commonly employed as a sedative agent to attenuate sympathetic tone and reduce norepinephrine (NE) levels. In the context of stroke-associated pneumonia (SAP), which is believed to arise from heightened sympathetic nervous system activity and elevated NE release,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Miaomiao, Luo, Qiong, Xu, Younian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433391/
https://www.ncbi.nlm.nih.gov/pubmed/37601052
http://dx.doi.org/10.3389/fphar.2023.1203646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433391/
https://www.ncbi.nlm.nih.gov/pubmed/37601052
http://dx.doi.org/10.3389/fphar.2023.1203646

Ejemplares similares